Category Archives: Research

OPDP Outlines New Research

Posted on September 27, 2022 by Mark Senak

FDA published notice recently that the Office of Prescription Drug Promotion (OPDP) was proposing some new research related to the promotion of medicines by pharmaceutical companies. The research was new (kind of) but the direction was more of the same … Continue reading →

Posted in FDA Policy, Research | Tagged , , | Comments Off on OPDP Outlines New Research

Precision Medicine and FDA – Emerging Cloud Platform in Beta

Posted on December 8, 2015 by Mark Senak

In his State of the Union message this year, President Obama announced a new effort in the way research is done when he unveiled the Precision Medicine Initiative (PMI). The stated goal of this initiative is to begin the transition from … Continue reading →

Posted in Research | Comments Off on Precision Medicine and FDA – Emerging Cloud Platform in Beta

Tap, Tap, Tap … Waiting for an Alzheimer’s Test? A Spinal Tap Test Emerges.

Posted on August 10, 2010 by Mark Senak

 A headline that has been both craved and feared appeared yesterday:  "Spinal-Fluid Test is Found to Predict Alzheimer's" The New York Times reports that the Archives of Neurology is today publishing a study on a test for Alzheimer's that is … Continue reading →

Posted in Current Affairs, Research | 1 Comment

Progress in Cancer Drugs

Posted on May 22, 2008 by Mark Senak

CBS is running a series on the progress in the development of cancer drugs.  Here is a clip from yesterday that discusses how the FDA manages the approval of cancer drugs:

Posted in Research | 3 Comments

Alzheimer’s = An Insidious Disease State (AIDS)

Posted on June 11, 2007 by Mark Senak

In the Sunday New York Times Business Section, there was an article about Alzheimer’s research.  As I read it, I was struck by the current state of research and the way it mimicked the AIDS epidemic during the late 1980s.  … Continue reading →

Posted in Research | 4 Comments